CI Canadian Convertible Bond ETF Common (CXF) Competitors C$10.10 +0.06 (+0.60%) (As of 09/17/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlines CXF vs. CRDL, FRX, APM, IPA, MDNA, GXE, ITH, GPH, EQ, and WMDShould you be buying CI Canadian Convertible Bond ETF Common stock or one of its competitors? The main competitors of CI Canadian Convertible Bond ETF Common include Cardiol Therapeutics (CRDL), Fennec Pharmaceuticals (FRX), Andean Precious Metals (APM), ImmunoPrecise Antibodies (IPA), Medicenna Therapeutics (MDNA), Gear Energy (GXE), International Tower Hill Mines (ITH), Graphite One (GPH), EQ (EQ), and WeedMD (WMD). These companies are all part of the "pharmaceutical products" industry. CI Canadian Convertible Bond ETF Common vs. Cardiol Therapeutics Fennec Pharmaceuticals Andean Precious Metals ImmunoPrecise Antibodies Medicenna Therapeutics Gear Energy International Tower Hill Mines Graphite One EQ WeedMD CI Canadian Convertible Bond ETF Common (TSE:CXF) and Cardiol Therapeutics (TSE:CRDL) are both small-cap manufacturing companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, risk, media sentiment, analyst recommendations, community ranking and institutional ownership. Does the media refer more to CXF or CRDL? In the previous week, CI Canadian Convertible Bond ETF Common had 2 more articles in the media than Cardiol Therapeutics. MarketBeat recorded 3 mentions for CI Canadian Convertible Bond ETF Common and 1 mentions for Cardiol Therapeutics. CI Canadian Convertible Bond ETF Common's average media sentiment score of 0.53 beat Cardiol Therapeutics' score of 0.00 indicating that CI Canadian Convertible Bond ETF Common is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CI Canadian Convertible Bond ETF Common 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cardiol Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is CXF or CRDL more profitable? CI Canadian Convertible Bond ETF Common's return on equity of 0.00% beat Cardiol Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets CI Canadian Convertible Bond ETF CommonN/A N/A N/A Cardiol Therapeutics N/A -108.43%-54.15% Do analysts rate CXF or CRDL? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CI Canadian Convertible Bond ETF Common 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ACardiol Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable valuation & earnings, CXF or CRDL? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCI Canadian Convertible Bond ETF CommonN/AN/AN/AN/AN/ACardiol TherapeuticsN/AN/A-C$29.34M-C$0.44-7.27 Do institutionals & insiders hold more shares of CXF or CRDL? 11.4% of Cardiol Therapeutics shares are owned by institutional investors. 4.6% of Cardiol Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the MarketBeat Community prefer CXF or CRDL? CI Canadian Convertible Bond ETF Common received 2 more outperform votes than Cardiol Therapeutics when rated by MarketBeat users. However, 69.23% of users gave Cardiol Therapeutics an outperform vote while only 57.89% of users gave CI Canadian Convertible Bond ETF Common an outperform vote. CompanyUnderperformOutperformCI Canadian Convertible Bond ETF CommonOutperform Votes1157.89% Underperform Votes842.11% Cardiol TherapeuticsOutperform Votes969.23% Underperform Votes430.77% SummaryCI Canadian Convertible Bond ETF Common beats Cardiol Therapeutics on 5 of the 9 factors compared between the two stocks. Ad GreenlaneThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start with diversification and experience. Founded in 2005, this company serves a diverse and expansive customer base with more than 8,000 retail locations, including licensed cannabis dispensaries, smoke shops, and specialty retailers. Learn more here. Get CI Canadian Convertible Bond ETF Common News Delivered to You Automatically Sign up to receive the latest news and ratings for CXF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CXF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat are MarkeBeat Followers?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CXF vs. The Competition Export to ExcelMetricCI Canadian Convertible Bond ETF CommonPharmaceutical Preparations IndustryManufacturing SectorTSE ExchangeMarket CapC$61.58MC$8.00BC$2.06BC$5.84BDividend Yield4.99%4.45%2.63%5.59%P/E RatioN/A19.5527.5224.71Price / SalesN/A240.79571.601,371.83Price / CashN/A37.6140.2281.40Price / BookN/A6.022.213.02Net IncomeN/AC$153.20MC$170.80MC$289.13M7 Day Performance0.20%13.08%1.62%1.87%1 Month Performance1.51%17.75%1.67%2.22%1 Year Performance7.91%26.78%10.29%31.35% CI Canadian Convertible Bond ETF Common Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRDLCardiol Therapeutics0 of 5 stars0.00 / 5 starsC$3.35-0.6%N/A+138.9%C$234.10MN/A-7.6120FRXFennec Pharmaceuticals0 of 5 stars0.00 / 5 starsC$7.39+0.1%N/AN/AC$202.19MC$48.89M82.1110Gap UpAPMAndean Precious Metals3.6323 of 5 stars3.63 / 5 starsC$1.16+7.4%C$1.70+46.6%N/AC$173.26MC$199.84M3.1430Insider BuyingNews CoveragePositive NewsGap UpIPAImmunoPrecise Antibodies0 of 5 stars0.00 / 5 starsC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080News CoverageGap DownMDNAMedicenna Therapeutics0 of 5 stars0.00 / 5 starsC$2.09+0.5%N/A+432.5%C$159.74MN/A-9.0920News CoverageGXEGear Energy3.4272 of 5 stars3.43 / 5 starsC$0.60-1.6%C$1.00+66.7%-31.4%C$158.15MC$134.93M12.001,310Positive NewsGap UpITHInternational Tower Hill Mines0 of 5 stars0.00 / 5 starsC$0.76+7.0%N/A+39.6%C$151.76MN/A-25.33220Gap UpGPHGraphite One0 of 5 stars0.00 / 5 starsC$0.75-1.3%N/A-32.7%C$103.94MN/A-10.7120EQEQ0 of 5 stars0.00 / 5 starsC$1.10+0.9%N/A+17.8%C$76.55MC$9.86M-15.7140Gap UpWMDWeedMD0 of 5 stars0.00 / 5 starsC$0.28-1.8%N/A+0.0%C$67.82MC$27.53M-0.66628Gap Up Related Companies and Tools Related Companies: CRDL Alternatives FRX Alternatives APM Alternatives IPA Alternatives MDNA Alternatives GXE Alternatives ITH Alternatives GPH Alternatives EQ Alternatives WMD Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:CXF) was last updated on 9/19/2024 by MarketBeat.com Staff From Our PartnersThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredNew September Stock WarningSeptember is the most volatile month of the year for stocks. And after the brutal tech selloff, one Wall St...Chaikin Analytics | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredWall St. Icon: Looming Financial Tsunami will Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event will hit the American...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CI Canadian Convertible Bond ETF Common Please log in to your account or sign up in order to add this asset to your watchlist. Share CI Canadian Convertible Bond ETF Common With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CXF Stock Alerts